Application of extracorporeal membrane oxygenation in early allograft dysfunction after heart transplantation
10.3969/j.issn.1674-7445.2023.01.012
- VernacularTitle:体外膜肺氧合在心脏移植术后早期移植物功能障碍中的应用
- Author:
Shanshan ZHENG
1
;
Zhe ZHENG
;
Yunhu SONG
;
Jie HUANG
;
Zhongkai LIAO
;
Jianfeng HOU
;
Hanwei TANG
;
Sheng LIU
Author Information
1. Department of Cardiac Surgery, Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing 100037, China
- Publication Type:Research Article
- Keywords:
Heart transplantation;
Early allograft dysfunction;
Extracorporeal membrane oxygenation;
Intra-aortic balloon pump;
Left ventricular ejection fraction;
Mechanical circulatory support;
Hemodynamics;
Vasoactive agent
- From:
Organ Transplantation
2023;14(1):93-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the effect of extracorporeal membrane oxygenation (ECMO) on early allograft dysfunction (EAD) after heart transplantation. Methods Clinical data of 614 heart transplant recipients were retrospectively analyzed. All recipients were divided into the ECMO group (n=43) and non-ECMO group (n=571) according to postoperative application of ECMO. In the ECMO group, the conditions of recipients undergoing ECMO after heart transplantation were summarized. Perioperative status and long-term prognosis of recipients were compared between two groups. Results Among 43 recipients undergoing ECMO, 17 cases underwent thoracotomy due to bleeding, 10 cases of infection, 4 cases of venous thrombosis of the lower limbs, and 1 case of stroke, respectively. Twenty-six recipients were recovered and discharged after successful weaning from ECMO, six died during ECMO support, six died after weaning from ECMO, five received retransplantation due to unsuccessful weaning from ECMO, and only one survived after retransplantation. Compared with the non-ECMO group, intraoperative cardiopulmonary bypass duration was significantly longer, the proportion of recipients requiring postoperative intra-aortic balloon pump (IABP), dialysis due to renal insufficiency, reoperation for hemostasis, infection, mechanical ventilation time≥96 h and tracheotomy was significantly higher, and the length of postoperative intensive care unit (ICU) stay was significantly longer in the ECMO group (all P < 0.05). The survival rate after discharge and 90-d survival rate in the ECMO group were 63% and 96%, significantly lower than 97% and 100% in the non-ECMO group (both P < 0.05). Survival analysis showed that the long-term survival rate in the ECMO group was significantly lower than that in the non-ECMO group (P < 0.05). After excluding the recipients who died within 90 d after heart transplantation, no significant difference was observed in the long-term survival rate (P > 0.05). Conclusions ECMO is an effective treatment of EAD after heart transplantation. The short-term survival rate of recipients using ECMO after heart transplantation is lower than that of those who do not use ECMO, and there is no significant difference in long-term survival of recipients surviving 90 d after heart transplantation.
